The deck reports FY26 consolidated revenue of ₹200.5 Cr with EBITDA of ₹64.6 Cr (32.2% margin) and PAT of ₹47.4 Cr (22.7% margin). The Green segment grew 52% YoY to ₹36.9 Cr while the High-tech segment declined to ₹163.6 Cr in FY26. Management declared a dividend of Rs.5 per share and highlighted operational focus on cost discipline, R&D and expanding CDMO (Avery Pharma) commercialisation and registrations. Cash from operations was ₹43.1 Cr and cash & cash equivalents rose to ₹26.8 Cr at year end.
